Blog

Takeda Pharmaceutical to Form New Joint Venture With PRA in Japan, Restructure Clinical Development

Takeda Pharmaceutical Co. Ltd. (TYO:4502) recently announced a new clinical development approach in Japan that it will run in partnership……

Please subscribe to read the full story.

Author

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *